BiotechTube
PleoPharma

PleoPharma

Cambridge, United States· Est.
pleopharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PleoPharma is a clinical-stage biotech company developing novel treatments for CNS and substance abuse disorders, with a primary focus on Cannabis Use Disorder (CUD). Founded by physicians who identified a significant unmet need in cannabis withdrawal, the company's lead asset has progressed through Phase 2 trials. With a seasoned leadership team and board, PleoPharma is positioned to advance its pipeline in a growing market that currently lacks FDA-approved pharmacological treatments.

Central Nervous System (CNS)Substance Abuse Disorders

Technology Platform

Focused on clinical development of small molecule therapies for CNS and substance abuse disorders; no specific proprietary platform detailed.

Opportunities

The primary opportunity is to be first-to-market with an FDA-approved pharmacotherapy for Cannabis Use Disorder, addressing a multi-million patient population in the U.S.
alone with no current drug competition.
Growing cannabis use and legalization trends expand the addressable market.
Regulatory pathways for substance abuse treatments are established and may offer expedited designations.

Risk Factors

High clinical risk associated with Phase 3 trial success and FDA approval.
Significant market education and payer reimbursement challenges as a pioneer in a new treatment category.
Substantial capital requirement for late-stage development poses financial and dilution risk for the private company.

Competitive Landscape

Direct competition is currently limited as there are no FDA-approved pharmacotherapies for CUD. Competition exists from behavioral therapies and a growing field of digital therapeutics for addiction. Other biopharma companies may be developing competing drug candidates, but PleoPharma's Phase 2 progress provides a potential timing advantage.

More companies in Small Molecule Drugs →More companies in United States →